FINWIRES · TerminalLIVE
FINWIRES

Travere Therapeutics Insider Sold Shares Worth $988,875, According to a Recent SEC Filing

作者

-- Eric M Dube, Director and Chief Executive Officer, on May 04, 2026, sold 22,500 shares in Travere Therapeutics (TVTX) for $988,875. Following the Form 4 filing with the SEC, Dube has control over a total of 432,886 common shares of the company, with 432,886 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1438533/000176349426000006/xslF345X05/form4-05062026_080504.xml

相关文章